51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-004598-83-GB (EUCTR)	22/10/2008	24/10/2008	High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intra ...	High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intra ...	Severe systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10042953;Term: Systemic ...	Trade Name: Cyclophosphamide Product Name: Cyclophosphamide INN or Proposed INN: CYCLOPHOSPHAMIDE Trade ...	EBMT (European group for Blood and Marrow Transplantation)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150		United Kingdom
2	NCT00278525 (ClinicalTrials.gov)	September 2005	15/1/2006	Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma	Trial of High Dose Cyclophosphamide and RabbitAntithymocyte Globulin (rATG) With Hematopoietic Stem ...	SYSTEMIC SCLERODERMA	Drug: standard of care;Procedure: stem cell transplantation	Northwestern University	NULL	Completed	N/A	60 Years	All	19	Phase 2	United States
3	NCT00016458 (ClinicalTrials.gov)	June 2000	6/5/2001	Phase II Pilot Study of Cyclophosphamide and RabbitAnti-Thymocyte Globulin as Salvage Therapy in Pat ...		Systemic Sclerosis	Drug: anti-thymocyte globulin;Drug: cyclophosphamide	Fred Hutchinson Cancer Research Center	NULL	Completed	N/A	64 Years	Both	20	Phase 2	United States

First Previous1Next Last